Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-17-060145

Chief Executive Officer bought 1,000 shares at $7.17 ($7,169)

From the SEC's structured data for this filing

Trades in this filing

Cohen Yuval · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-11-10 Purchase : show line 1 in the form +1,000 $7.17 $7,169 58,775 D
Open-market purchases · 1,000 sh · avg $7.17 · $7,169
Loading xslF345X03/doc4.xml…